Background: Studies from our laboratory have shown that the earliest stages of atherosderosis may be mediated by an autoimmune reaction against heat shock protein 60 (Hsp6O). The interactions of Hsp6O-specific T cells with arterial endothelial cells (EC) require expression of both Hsp6O and certain adhesion molecules shown to be induced simultaneously in EC by mechanical and other types of stress. Recently, it was shown that suppression of T cell-mediated immune responses by cydosporin A (CyA) enhanced atherosderotic lesion formation in mice. In contrast, aspirin was found to lower the risk of myocardial infarction in men. These conflicting observations may be due to different effects of anti-inflammatory agents on adhesion molecule and Hsp expression in EC, respectively. Material and Methods: In the present study, we analyzed the effects of CyA, aspirin, and indomethacin on T cell proliferation using a proliferation assay. To explore the expression of adhesion molecules, monocyte chemoattractant protein-I (MCP-1), and Hsp6O in human
Introduction
Results in the past few years from different laboratories suggest an immunological contri-bution to the development of atherosclerosis. It was shown that, in addition to macrophages, T lymphocytes are also a fundamental component of early atherosclerotic lesions (1, 2) , and these T lymphocytes are predominantly CD4+ interleukin-2 (IL-2R) and HLA-DR receptor positive, indicating an activated phenotype (3, 4) . Recently, it was shown that atheroscle-rotic lesions induced in mice or rabbits (5, 6) by a high cholesterol diet also exhibit infiltration and activation of T lymphocytes.
Based on observations in humans and experimental animals, we have advanced an immunological hypothesis for atherogenesis (7, 8) , in which cellular and humoral immune reactions to heat shock protein 60 (Hsp6O) have been identified as the initiating factors. This hypothesis is corroborated by the finding that immunization of normocholesterolemic rabbits with recombinant mycobacterial heat shock protein 65 (Hsp65) induces the development of arteriosclerotic lesions, and that the majority of T lymphocytes isolated from these lesions react against Hsp65 in vitro (5,9). Furthermore, an epidemiological study showed that serum antibody titers to hsp65 were significantly increased in clinically healthy subjects with sonographically demonstrable carotid atherosclerosis compared to those without lesions (10) . Hsp65 belongs to a family of proteins induced by various forms of stress, such as temperature, cytokines, toxins, and oxidized low-density lipoproteins. One of their important functions is protecting other cellular proteins from denaturation to maintain their cellular functions ( 1i). Hsps are phylogenetically highly conserved; mycobacterial Hsp65 exhibits a >50% protein sequence homology to human Hsp6O (12) . Hsp antigens are also important in inducing protective immune responses but, in view of the high sequence homology to Hsp6O, this protection may have to be "paid for" in humans by an autoimmune cross-reaction (13) .
Previous studies suggested that recruitment of activated T lymphocytes into inflammation sites is mediated by several adhesion molecules, e.g., the intercellular adhesion molecule-I (ICAM-1), vascular cell adhesion molecule-I (VCAM-1), endothelial leukocyte adhesion molecule-I (ELAM-1; E-selectin), and chemoattractant proteins, such as monocyte chemoattractant protein-I (MCP-1), expressed by endothelial cells. This mechanism was also suggested for the recruitment of T lymphocytes into the arterial wall (14, 15) . The induction of adhesion molecule expression in endothelial cells overlaying atherosclerotic lesions has been demonstrated (16) (17) (18) , and data from our laboratory revealed that different stressors, such as hemodynamic turbulance, H202, tumor necrosis factor a (TNF-a), and E. coli lipopolysaccharide, induce co-expression of adhesion molecules and Hsp6O in endothelial cells in vivo and in vitro (19, 20) , providing the prerequisites for recruitment of anti-Hsp6O-reactive T cells into the arterial intima and subsequent initiation of an autoimmune response.
The role of immune reactions in atherogenesis was analyzed by manipulating the immune system in various animal models of atherosclerosis. Cyclosporin A (CyA)-mediated T lymphocyte immunosuppression of rabbits and mice fed a cholesterol-rich diet resulted in enhanced atherosclerosis (21, 22) . In contrast, aspirin, another anti-inflammatory agent, lowered the incidence of myocardial infarction and stroke in men (23) . These conflicting observations may result from different mechanisms of action of these immunosuppressive and anti-inflammatory agents on adhesion molecule and Hsp expression, respectively, in endothelial cells. Transcriptional induction of the corresponding genes by various stressors is mediated by transcription factors that bind to specific DNA elements in the promotor region of these genes. Transcription factors, such as nuclear factor-KB (NF-KB) and heat shock factor-I (HSF-1), are pleiotropic regulators of many genes involved in immune and inflammatory responses, including adhesion molecules and Hsps (24) . Most studies analyzing the effects of antiinflammatory agents focused on the modulation of NF-KB activity by aspirin in cytokine-stimulated endothelial cells (25, 26) . However, little is known about the action of immunosuppressive agents on the activity of other transcription factors in endothelial cells and their potential to induce adhesion molecule and Hsp expression. To detail the potential role of immunosuppressive and anti-inflammatory agents in atherosclerosis, we analyzed the effects of CyA, aspirin, and indomethacin on the expression of ICAM-1, VCAM-1, ELAM-1, and MCP-1, and of Hsp6O and Hsp7O by endothelial cells after cytokine activation in vitro. In parallel, the efficiency of this treatment was assessed by analyzing peripheral blood lymphocyte proliferation in response to specific antigen stimulation (influenza virions). We also analyzed the role of transcription factor activity in endothelial cells after treatment with these agents to demonstrate how the effects of the immunosuppressive agents are mediated in endothelial cells on a molecular level. CyA from Sandimmuneg (Sandoz, Switzerland) was dissolved in the solution supplied by the manufacturer and diluted to end concentrations in endothelial cell or RPMI medium. Aspirin (acetylsalicylic acid, Sigma) was dissolved in EC medium to give a 1 M (180.2 mg/ml) solution. The pH of the medium containing aspirin was adjusted prior to usage. Indomethacin (Sigma) was dissolved in dimethylsulfoxide (DMSO; Merck, Darmstadt, Germany) to prepare a 10 mg/ml solution. This solution was then diluted in EC or RPMI medium to the final concentrations given in the Results section.
Materials and Methods
RNA Isolation and Northern Blots Total RNA was isolated from EC according to a standard protocol (28) . The RNA was electrophoresed in a 1 % formaldehyde agarose gel, blotted on a nylon membrane (Zeta probe, BioRad, Richmond, VA) and UV cross-linked. The filters were hybridized with 32P-labeled cDNA (32P-a dCTP, Amersham, London) and random primed using a labeling kit (Boehringer-Mannheim, Mannheim, Germany) for ICAM-1, VCAM-1, ELAM-1, Hsp6O, Hsp7O, B-actin, or GAPDH at 63°C in hybridization buffer (29) . After three washing steps, filters were exposed to X-OMAT X-ray film from Kodak (Rochester, NY) at -700C. The cDNA clones used in these experiments were the same as described earlier (20) .
Extraction of Nuclear Protein for NF-KB and HSF-I Detection EC were washed in ice-cold PBS, harvested in 1 ml TE-buffer (10 mM Tris Cl, 1 mM EDTA, pH 8, Merck) and pelleted at 17,000 x g for 5 min. The pellet was resuspended in buffer A containing 10 mM Hepes (pH 7.9), 0.1 mM EDTA, 10 mM KC1, 0.1 mM EGTA, 1 mM DTT supplemented with 400 ,uM phenylmethylsulfonyl fluoride (PMSF), 2 ,uM leupeptin, 10 U/ml aprotinin, and 1 mM pefablock SC [4-(2-aminoethyl) -benzenesulfonyl floride hydrochloride, Boehringer-Mannheim] and incubated on ice for 15 min. After addition of 0.6% nonidet P-40 (Igepal CA-630, Sigma), the nuclei were pelleted at 17,000 X g for 0.5 min and resuspended in buffer B containing 20 Figure 1 slhows that aspirin and CyA inhibited PBMC proliterationi in a dose-dependent fashion, whereas iindonmethacin had no suppressive effect (Fig. 1 C) . Aspirin at concentrations betweenl 5 imiM (0.9 ing/ml) and 40 mM (7.2 mg/ml) an(d CyA at concentrations of 100 ng/rnl anid imiore inhibited PBMC proliferation (Fig. 1 ) in a dose-dependent manner. To examine interiindividual differences in the PBMC Figure 2 demonstrates that TNF-a induced expression of adhesion molecules ICAM-1, VCAM-1, ELAM-1, and the chemoattractant protein MCP-1. This induction was constantly suppressed by concentrations of aspirin between 5 and 40 mM (0.9 mg/ml-7.2 mg/ml) ( Fig. 2A) . In contrast, CyA and indomethacin did not suppress induction of adhesion molecules and MCP-1 by TNF-a (Fig. 2B, C) (Fig. 4A ). TNF-a-induced NF-KB activity in EC is suppressed by aspirin (Fig. 5A ), but not by indomethacin (Fig. 5B) or CyA (Fig. 5C ). The inhibition of NF-KB activity was observed by treatment with concentrations of aspirin ranging from 10 to 40 mM (1.8 mg/ml-7.2 mg/ml) (Fig. 5A ). The specificity of the shown NF-KB binding was confirmed by competition with a 50-fold excess of cold NF-KB, a supershift using an anti-NF-KB antibody, and by using a 50-fold excess of cold HSE (Fig. 6 ).
HSF-1 tivated transcription factor NF-KB. Endothelial cells were treated with TNF-a (10 ng/ml) to activate the transcription factor NF-KB and with the various concentrations of the respective agents for 30 min. Only aspirin (A) showed an inhibitory effect on the activation of NF-KB, whereas indomethacin (B) and CyA (C) had no effect.
blocking responses of activated T cells to presentation of antigen (31) . Since CyA is an effective suppressor of T cell activation, it was used as a possible tool to examine the role of T cells in atherogenesis. Surprisingly, it was shown that CyA administration was associated with an increased severity of atherosclerosis in cholesterolfed rabbits (21) and mice given an atherogenic diet (22) . (21) . We suggest, therefore, that the enhancement of atherosclerosis in cholesterol-fed rabbits and mice (21, 22 ) is due to induction of Hsp6O by EC. Since the immunosuppressive effect of CyA is most prominent during the induction phase of a T cell response, and less so in Hsp6O-reactive memory cells, the Hsp6O and adhesion molecule-inducing effect obviously overrides the former, although the mechanism of induction is not known. The promotor region of the human Hsp6O gene remains to be cloned and analyzed. Thus, it is difficult to define the transcription factor(s) responsible for CyA-induced Hsp6O expression. We found that CyA did not induce HSF-1 in EC, as was shown to be necessary for Hsp7O gene expression in many different cell types (33) .
More recently, Drew and Tipping demonstrated that CyA treatment reduces atherosclerosis in cholesterol-fed rabbits (34) . The authors showed that no CD4+ cells could be detected in the few plaques of CyA-treated animals, whereas circulating T cell numbers and subsets were unaffected. In this study, rabbits were analyzed 4 weeks after starting the cholesterol-rich diet compared to studies by others in which lesions developed over periods of 4-8 months (21) . It is tempting to suggest that, in CyA-treated animals, lesion formation might be delayed, but not inhibited.
Aspirin and indomethacin belong to a class of nonsteroidal anti-inflammatory drugs, and as-pirin is commonly used to treat certain symptoms of inflammatory and cardiovascular diseases. Recently, it was shown that aspirin treatment of clinically apparently healthy men with high base-line C-reactive protein serum levels was associated with a decreased risk for a first myocardial infarction, suggesting that the antiinflammatory effect of aspirin may have clinical benefits in preventing cardiovascular disease (23) . However, in contrast to its use in preventing atherosclerosis, higher doses of aspirin are necessary to treat inflammatory diseases (35) . Recent studies have shown that high doses of aspirin inhibit the activation of NF-KB (Fig. 5A ) by preventing inhibitor-kB degradation, which is necessary for release and nuclear translocation of NF-KB from the inactive cytoplasmic complex (25, 26, 36) . Suppression of NF-KB activation correlates with decreased adhesion molecule and MCP-1 expression by anti-inflammatory agents (Fig. 3) . High doses of aspirin (from 10 to 40 mM; 1.8 mg/ml to 7.2 mg/ml) may be observed in vivo because the local conditions may favor its uptake and concentration, possibly enhancing inhibition of NF-KB at these sites (37) . In the current study, we demonstrated that doses of aspirin that effectively suppress adhesion molecule and MCP-1 expression also effectively induce Hsp6O and Hsp7O. Hsp7O expression induced by aspirin correlates with HSF-1 activity in endothelial cells, suggesting that HSF-1 is involved in aspirin-induced Hsp7O expression. Jurivich et al. (38) have shown that sodium salicylate at concentrations as high as 20 mM (3.6 mg/ml) induces HSF binding to HSE of the Hsp7O gene, even though it was unable to induce Hsp7O transcription in HeLa cells. We found HSF-1 binding to HSE and transcription of Hsp70 gene only at aspirin concentrations of 40 mM 7.2 mg/ ml. The expression of Hsp6O is induced at concentrations of aspirin ranging from 10 to 40 mM.
Our data suggest that high doses of aspirin prevent the recruitment of activated T cells (even of known specificity) into sites of inflammation via suppression of adhesion molecules and MCP-1, in concert with the finding that aspirin inhibits NF-KB activation (Fig. 5A) . Neither indomethacin nor CyA showed this inhibitory effect (Fig. SB, C) . Furthermore, aspirin inhibited the proliferative response of PBMC to influenza virus mix in vitro, a suppression that was effective at aspirin concentrations that induced Hsp6O expression. Therefore, we hypothesize that the recruitment of anti-Hsp6O-reactive T cells into arterial intima and the subsequent initiation of a reaction against Hsp6O could be prevented by aspirin. Furthermore, we assume that the induction of Hsp6O expression by aspirin cannot overcome the suppressive effects of aspirin on adhesion molecule expression.
We have also demonstrated that addition of indomethacin to T cell cultures failed to suppress the proliferative response to influenza antigen. As shown in Figure 1C , indomethacin slightly, but not significantly, induced T cell proliferation, and also reversed immune suppressive phenomena in vivo (39) and in vitro (40, 41) by inhibiting immune cell release of prostaglandin, which inhibits IL-2 production and hence proliferation of responder T cells (41) . Furthermore, indomethacin did not inhibit NF-KB activity and adhesion molecule or MCP-1 expression in EC after TNF-a stimulation, and induced Hsp6O and Hsp7O expression only at high doses.
In summary, our data suggest that the different actions of immunosuppressive agents on adhesion molecule, MCP-1, and Hsp6O expression in EC could overcome the suppression of the cellular immune response by these agents, and may explain the atherosclerosis-promoting effect of CyA and the protective effect of aspirin, respectively. Further investigations on immune system suppression in animal models of atherosclerosis will elucidate how and when lymphocytes influence the atherosclerotic disease process.
